Become A Wiser, More Profitable Investor

JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus - Yahoo Finance

Johnson & Johnson JNJ set the ball rolling for the pharma and medical device manufacturing space’s third-quarter 2023 earnings on Oct 17, before the opening bell. The world's biggest healthcare products maker continued with its long streak of earnings beat. It topped revenue and earnings estimates as well as lifted the full-year outlook.Despite the solid results, JNJ shares declined 0.9% on the day. Investors seeking to tap the opportune moment should consider ETFs having the largest allocation to this diversified drug maker. These include iShares U.S. Pharmaceuticals ETF IHE, Health Care Select Sector SPDR Fund XLV, iShares U.S. Healthcare ETF IYH, First Trust Nasdaq Pharmaceuticals ETF FTXH and Vanguard Health Care ETF VHT.Earnings per share came in ...

Yahoo     Oct 18, 2023